Lysoway Therapeutics, Inc.

About Lysoway Therapeutics, Inc.

Lysoway Therapeutics is a leader in lysosomal ion channel biology, focused on developing therapies to address metabolic storage disorders and neurodegenerative diseases by restoring lysosomal function through ion channel modulation.

Products & Services

Lysosomal Ion Channel Modulators:Small-molecule compounds targeting channels like TRPML1 and TMEM175 to restore autophagic flux, enhance plasma membrane repair, and treat neurodegenerative and rare diseases with lysosomal dysfunction.

Pipeline Programs:Synergistic programs addressing multiple distinct lysosomal and autophagy deficiencies.

Specialties

Lysosomal Ion Channel Biology Neurodegenerative Diseases Metabolic Storage Disorders Drug Discovery and Development Autophagy and Lysosomal Function Restoration

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 2930000 MR: - FA: $2.93 million FAN: 2930000	D: 2025-08-05 FD: 2025-08-05	1 investors

Grant Latest

2025-08-05

$2.9M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Junsheng Yang

Senior Director, Discovery Research

V

Valerie Cullen

SVP, Head of Research and Translational Sciences

X

Xiang Yang Yu

SVP, Head of Chemistry and Program Management

Y

Yongchang Qiu

President and CEO

View 1 more team members with Pro

Unlock Full Team Directory

Recent News